These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 30381016)
61. Use of quantitative real-time PCR to monitor the shedding and treatment of chlamydiae in the koala (Phascolarctos cinereus). Markey B; Wan C; Hanger J; Phillips C; Timms P Vet Microbiol; 2007 Mar; 120(3-4):334-42. PubMed ID: 17178441 [TBL] [Abstract][Full Text] [Related]
62. Genetic diversity in the plasticity zone and the presence of the chlamydial plasmid differentiates Chlamydia pecorum strains from pigs, sheep, cattle, and koalas. Jelocnik M; Bachmann NL; Kaltenboeck B; Waugh C; Woolford L; Speight KN; Gillett A; Higgins DP; Flanagan C; Myers GS; Timms P; Polkinghorne A BMC Genomics; 2015 Nov; 16():893. PubMed ID: 26531162 [TBL] [Abstract][Full Text] [Related]
63. Culture-independent genome sequencing of clinical samples reveals an unexpected heterogeneity of infections by Chlamydia pecorum. Bachmann NL; Sullivan MJ; Jelocnik M; Myers GS; Timms P; Polkinghorne A J Clin Microbiol; 2015 May; 53(5):1573-81. PubMed ID: 25740768 [TBL] [Abstract][Full Text] [Related]
64. Koala cathelicidin PhciCath5 has antimicrobial activity, including against Chlamydia pecorum. Peel E; Cheng Y; Djordjevic JT; O'Meally D; Thomas M; Kuhn M; Sorrell TC; Huston WM; Belov K PLoS One; 2021; 16(4):e0249658. PubMed ID: 33852625 [TBL] [Abstract][Full Text] [Related]
65. Necropsy findings of koalas from the Mount Lofty Ranges population in South Australia. Speight KN; Hicks P; Graham C; Boardman W; Breed WG; Manthorpe E; Funnell O; Woolford L Aust Vet J; 2018 May; 96(5):188-192. PubMed ID: 29691854 [TBL] [Abstract][Full Text] [Related]
66. Vaccination of koalas (Phascolarctos cinereus) with a recombinant chlamydial major outer membrane protein adjuvanted with poly I:C, a host defense peptide and polyphosphazine, elicits strong and long lasting cellular and humoral immune responses. Khan SA; Waugh C; Rawlinson G; Brumm J; Nilsson K; Gerdts V; Potter A; Polkinghorne A; Beagley K; Timms P Vaccine; 2014 Oct; 32(44):5781-6. PubMed ID: 25196393 [TBL] [Abstract][Full Text] [Related]
67. Immunization of a wild koala population with a recombinant Chlamydia pecorum Major Outer Membrane Protein (MOMP) or Polymorphic Membrane Protein (PMP) based vaccine: New insights into immune response, protection and clearance. Desclozeaux M; Robbins A; Jelocnik M; Khan SA; Hanger J; Gerdts V; Potter A; Polkinghorne A; Timms P PLoS One; 2017; 12(6):e0178786. PubMed ID: 28575080 [TBL] [Abstract][Full Text] [Related]
68. TESTIS ABNORMALITIES IN A POPULATION OF SOUTH AUSTRALIAN KOALAS (PHASCOLARCTOS CINEREUS). Buchanan C; Woolford L; Stephenson T; Hoebergen M; Kovac JH; Breed WG; Speight N J Wildl Dis; 2022 Jan; 58(1):158-167. PubMed ID: 34797903 [TBL] [Abstract][Full Text] [Related]
70. Characterisation of CD4 T cells in healthy and diseased koalas (Phascolarctos cinereus) using cell-type-specific monoclonal antibodies. Mangar C; Armitage CW; Timms P; Corcoran LM; Beagley KW Dev Comp Immunol; 2016 Jul; 60():80-90. PubMed ID: 26905635 [TBL] [Abstract][Full Text] [Related]
71. Molecular characterisation and expression analysis of interferon gamma in response to natural Chlamydia infection in the koala, Phascolarctos cinereus. Mathew M; Pavasovic A; Prentis PJ; Beagley KW; Timms P; Polkinghorne A Gene; 2013 Sep; 527(2):570-7. PubMed ID: 23792018 [TBL] [Abstract][Full Text] [Related]
72. Koala immunology and infectious diseases: How much can the koala bear? Madden D; Whaite A; Jones E; Belov K; Timms P; Polkinghorne A Dev Comp Immunol; 2018 May; 82():177-185. PubMed ID: 29382557 [TBL] [Abstract][Full Text] [Related]
73. Chronic Infection of the Prostate by Chlamydia muridarum Is Accompanied by Local Inflammation and Pelvic Pain Development. Sanchez LR; Breser ML; Godoy GJ; Salazar FC; Mackern-Oberti JP; Cuffini C; Motrich RD; Rivero VE Prostate; 2017 Apr; 77(5):517-529. PubMed ID: 28093789 [TBL] [Abstract][Full Text] [Related]
74. Antibiotic treatment of Chlamydia-induced cystitis in the koala is linked to expression of key inflammatory genes in reactive oxygen pathways. Phillips S; Quigley BL; Aziz A; Bergen W; Booth R; Pyne M; Timms P PLoS One; 2019; 14(8):e0221109. PubMed ID: 31415633 [TBL] [Abstract][Full Text] [Related]
75. Susceptibility to a sexually transmitted disease in a wild koala population shows heritable genetic variance but no inbreeding depression. Cristescu RH; Strickland K; Schultz AJ; Kruuk LEB; de Villiers D; Frère CH Mol Ecol; 2022 Nov; 31(21):5455-5467. PubMed ID: 36043238 [TBL] [Abstract][Full Text] [Related]
76. Developing noninvasive methodologies to assess koala population health through detecting Chlamydia from scats. Cristescu RH; Miller RL; Schultz AJ; Hulse L; Jaccoud D; Johnston S; Hanger J; Booth R; Frère CH Mol Ecol Resour; 2019 Jul; 19(4):957-969. PubMed ID: 30681773 [TBL] [Abstract][Full Text] [Related]
77. Development and application of two multiplex real-time PCR assays for detection and speciation of bacterial pathogens in the koala. Hulse LS; Hickey D; Mitchell JM; Beagley KW; Ellis W; Johnston SD J Vet Diagn Invest; 2018 Jul; 30(4):523-529. PubMed ID: 29629645 [TBL] [Abstract][Full Text] [Related]
78. A 5-year Chlamydia vaccination programme could reverse disease-related koala population decline: predictions from a mathematical model using field data. Craig AP; Hanger J; Loader J; Ellis WA; Callaghan J; Dexter C; Jones D; Beagley KW; Timms P; Wilson DP Vaccine; 2014 Jul; 32(33):4163-70. PubMed ID: 24877768 [TBL] [Abstract][Full Text] [Related]
79. Inbreeding and disease avoidance in a free-ranging koala population. Schultz AJ; Cristescu RH; Hanger J; Loader J; de Villiers D; Frère CH Mol Ecol; 2020 Jul; 29(13):2416-2430. PubMed ID: 32470998 [TBL] [Abstract][Full Text] [Related]